NASDAQ: ASBP
Aspire Biopharma Holdings Inc Stock Ownership - Who owns Aspire Biopharma Holdings?

Insider buying vs selling

Have Aspire Biopharma Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Donald G. FellDirector2025-06-0510,500$0.39
$4.10kBuy
Donald G. FellDirector2025-06-0510,500$0.39
$4.10kBuy
Donald G. FellDirector2025-06-0510,500$0.39
$4.10kBuy
Donald G. FellDirector2025-06-049,500$0.39
$3.71kBuy
Donald G. FellDirector2025-06-049,500$0.39
$3.71kBuy
Donald G. FellDirector2025-06-049,500$0.39
$3.71kBuy

1 of 1

ASBP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ASBP insiders and whales buy or sell their stock.

ASBP Shareholders

What type of owners hold Aspire Biopharma Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Surendra K. Ajjarapu160.69%4,317,500$4.53MInsider
Powerup Sponsor LLC106.81%2,870,000$3.01MInsider
Ubs Group Ag93.60%2,514,873$2.64MInstitution
Crewe Advisors LLC30.27%813,427$854.10kInstitution
Jane Street Group LLC25.61%688,143$722.55kInstitution
Vanguard Group Inc15.95%428,552$449.98kInstitution
Optivise Advisory Services LLC13.30%357,340$375.21kInstitution
Xtx Topco Ltd9.88%265,471$278.74kInstitution
Geode Capital Management LLC9.21%247,555$259.93kInstitution
Procyon Advisors LLC8.66%232,661$244.29kInstitution

1 of 3

ASBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ASBP48.63%51.37%Net Buying
ADIL43.37%56.63%
AZTR1.39%98.08%
BRTX0.32%99.68%Net Buying
ARTL10.57%89.43%

Aspire Biopharma Holdings Stock Ownership FAQ

Who owns Aspire Biopharma Holdings?

Aspire Biopharma Holdings (NASDAQ: ASBP) is owned by 253.95% institutional shareholders, 268.24% Aspire Biopharma Holdings insiders, and 0.00% retail investors. Surendra K. Ajjarapu is the largest individual Aspire Biopharma Holdings shareholder, owning 4.32M shares representing 160.69% of the company. Surendra K. Ajjarapu's Aspire Biopharma Holdings shares are currently valued at $4.53M.

If you're new to stock investing, here's how to buy Aspire Biopharma Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.